ANASTASIA GALANOS: Open Payments
NPI 1710740964 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 61 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,118 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $206 |
| Regeneron Healthcare Solutions, Inc. | 8 | $201 |
| Novartis Pharmaceuticals Corporation | 9 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $88 |
| Incyte Corporation | 4 | $73 |
| Janssen Biotech, Inc. | 4 | $67 |
| Galderma Laboratories, L.P. | 4 | $67 |
| GENZYME CORPORATION | 2 | $42 |
| Journey Medical Corporation | 2 | $36 |
| Amgen Inc. | 2 | $36 |
Products named: DUPIXENT, COSENTYX, SKYRIZI, RINVOQ, ILUMYA, OPZELURA, TREMFYA, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
